Comparing the effect of short term post meals and bedtime calcium supplementation on the C-terminal telopeptide crosslinks and PTH levels in postmenopausal osteopenic women
- PMID: 16858933
Comparing the effect of short term post meals and bedtime calcium supplementation on the C-terminal telopeptide crosslinks and PTH levels in postmenopausal osteopenic women
Abstract
Background: Calcium supplement for postmenopausal osteopenic women can significantly reduce bone loss and the risk of fractures. However, the optimal time for calcium supplementation remains controversial.
Objective: The aim of the present study was to compare the effect of twice daily post meals and bedtime calcium supplementation for a two week periods, on C-terminal telopeptide crosslinks and PTH levels in postmenopausal osteopenic women.
Design: A randomized double blind placebo-control, crossover design, was carried out on 3 consecutive periods 3 of a 2-week treatment regimen. In the first period, all the subjects randomly received either two calcium carbonate tablets (Chalk Cap all subjects randomly received either two calcium 334 mg per tab) or placebo at bedtime with one tablet of calcium tablet or placebo after breakfast and dinner for two weeks. In the second period, subjects received only placebo tablets after the meals and at bedtime for 2 weeks. In the third period subjects received either calcium carbonate or placebo for another two weeks. The C-terminal telopeptide crosslinks were measured at 8.00 am and serum PTH were sampled at 8 time points (12.00 am, 2.00 am, 4.00 am, 6.00 am, 8.00 am, 9.00 am, 5.00 pm, and 7.00 pm respectively by the end of each study at the first and third period.
Results: The present study showed thirty-six postmenopausal subjects (mean age 63.9 + 3.66 years) participated in the present study. The mean T-score BMD of the spine and hip were -2.96 + 0.87 and -2.96 + 0.77 gm/cm2. C-terminal telopeptide crosslinks levels of the bedtime supplementation were significantly lower than the post meal supplementation (0.228 + 0.002 ng/ml vs 0.313 + 0.003 ng/ml, p < 0.001). The mean night time serum PTH level during the bedtime was significantly lower than the post meal period. (25.17 + 2.31 pg/ml vs 31.930 + 2.677 pg/ml, p < 0.001). No differences in the post meal PTH level between two periods were observed
Conclusion: The bedtime calcium supplementation appeared to reduce the bone resorption marker and night time serum PTH levels greater than the post meal calcium supplementation in this short term period study. However, long term comparison may be needed.
Similar articles
-
Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss.Maturitas. 2008 Jun 20;60(2):170-6. doi: 10.1016/j.maturitas.2008.05.003. Epub 2008 Jun 24. Maturitas. 2008. PMID: 18572334 Clinical Trial.
-
Suppression of parathyroid hormone and bone resorption by calcium carbonate and calcium citrate in postmenopausal women.Calcif Tissue Int. 2008 Aug;83(2):81-4. doi: 10.1007/s00223-008-9148-z. Epub 2008 Jun 14. Calcif Tissue Int. 2008. PMID: 18553042 Clinical Trial.
-
Inhibition of bone turnover by milk intake in postmenopausal women.Br J Nutr. 2008 Oct;100(4):866-74. doi: 10.1017/S0007114508937429. Epub 2008 Feb 26. Br J Nutr. 2008. PMID: 18298870
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Potential use of biochemical markers of bone turnover for assessing the effect of calcium supplementation and predicting fracture risk.Clin Ther. 2005 Mar;27(3):299-308. doi: 10.1016/j.dinthera.2005.03.003. Clin Ther. 2005. PMID: 15878383 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous